This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Elsevier To Collaborate With Knewton To Build Adaptive Learning Products For Nursing, Health Professions, And Medical Students Globally

PHILADELPHIA, June 12, 2014 /PRNewswire/ --

Elsevier to use Knewton technology to create next generation of digital course materials  

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today a collaboration with Knewton, a leading adaptive learning company. Starting with courses for nursing and health professions students, Elsevier will use Knewton's infrastructure to power personalized digital solutions that continuously adjust to each individual's unique learning needs.

"Elsevier's high-quality educational materials prepare students in nursing, health professions, and medicine to play critical roles in the future of global health," said Jose Ferreira, Founder and CEO, Knewton. "We look forward to working with Elsevier to help millions more students unlock personalized learning experiences and better master the material needed to prepare for these important careers."

Elsevier is a global leader in educational learning solutions, with a strong focus on research, science, and healthcare, and a mission to develop solutions that deliver improved outcomes for global health. Elsevier publishes about 25 percent of the world's clinical content, and nearly every nursing student in North America uses an Elsevier resource in training or in practice. Knewton technology will analyze what every student knows and how he or she learns best, and then provide personalized recommendations to help more students master the Elsevier material. Elsevier's decision to work with Knewton reflects an increasing global demand for personalized learning materials and Knewton's leadership position in data analytics and adaptive learning.

"Today, the demand for health and medical professionals around the world is growing rapidly, and higher education institutions need the best materials to help students prepare for careers in the health industry," said John Danaher, President, Elsevier Education. "Our Knewton-powered solutions will help transform health science education for professors and students, inside and outside the classroom. When students learn more effectively, they will experience more success when they launch into careers. Elsevier's mission is to improve student, program, and institutional outcomes by focusing on development of innovative solutions that will deliver value for customers, businesses, and shareholders. Our work with Knewton combines our world-class educational content with the latest analytics and technology so academic institutions can analyze the effectiveness of their curriculum and make the necessary adjustments to produce better outcomes for students."

To learn more about the Elsevier-Knewton collaboration and other Elsevier initiatives, visit Elsevier's "Stay on Target" booth (#361) at the Association of Private Sector Colleges and Universities (APSCU) Annual Conference and Expo in Las Vegas, June 16-18, 2014.

About Knewton 

Knewton's goal is to personalize lessons for students around the world. Education companies use Knewton technology to power course materials that dynamically adapt to each student's unique needs. By analyzing data to figure out what a student knows, Knewton recommends what to study next, helping more students master material and get ahead. Knewton-powered analytics identify knowledge gaps and predict performance to help educators, parents, and administrators better support every student.

Knewton was founded in 2008 and has offices in New York City and London.

About Elsevier 

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey - and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contacts Christopher Capot Director, Corporate Relations Elsevier +1-212-633-3164 c.capot@elsevier.com press@knewton.com +1-917-284-9829

SOURCE Elsevier

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,070.40 +46.34 0.26%
S&P 500 2,114.49 +6.20 0.29%
NASDAQ 5,016.9290 +11.5380 0.23%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs